SLAMF1 and B-cell chronic lymphocytic leukemia: Moreover, CLL cases with high SLAMF1/7 receptor expression showed a trend towards longer overall survival also within the M-CLL subset (SLAMFhigh = 36, SLAMFlow = 62 patients; Supplementary Fig. S2B).